Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03122535 · ClinicalTrials.gov registry record · NA
70 vs 110 Degree Side-cut Angles in Femtosecond LASIK
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT03122535: Completed NA study, sponsored by University of Utah.
NCT03122535 is a NA study that has completed, run by University of Utah. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03122535, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this study is to compare 70 and 110 degree side-cut angles on the same patient undergoing Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK).
Primary Outcome
Vision testing without correction, both eyes using Snellen Eye chart
Interventions
- DEVICE FS-LASIK 70 degree side-cut angle
- DEVICE FS-LASIK 110 degree side-cut angle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2014-10-07 |
| Est. Completion | 2019-03-21 |
| Phase | NA |
What the finished NCT03122535 record still lists
NCT03122535 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which FS-LASIK 70 degree side-cut angle is the first listed.
NCT03122535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03122535 about?
NCT03122535 is a clinical study titled "70 vs 110 Degree Side-cut Angles in Femtosecond LASIK". The purpose of this study is to compare 70 and 110 degree side-cut angles on the same patient undergoing Femtosecond Laser-assisted in Situ Keratomileusis (FS-LASIK).
What is the current status of trial NCT03122535?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2014-10-07. Estimated completion is 2019-03-21.
What interventions are being tested in trial NCT03122535?
The interventions under investigation include: FS-LASIK 70 degree side-cut angle (DEVICE), FS-LASIK 110 degree side-cut angle (DEVICE).
Who is sponsoring clinical trial NCT03122535?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03122535's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI